Eliciting the Impact of Metformin and Statins on Prostate Cancer Outcomes from a Real-life National Database Analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Statin use may improve prostate cancer survival, especially with androgen deprivation therapy, but not with radical prostatectomy. Combined statin and metformin use showed protective effects in some prostate cancer patients.
Area Of Science
- Oncology
- Pharmacology
- Epidemiology
Background
- Contradictory findings exist on statin and metformin use impacting prostate cancer (PC) survival.
- PC patients often have comorbidities like dyslipidemia and type 2 diabetes (T2D), leading to medication use.
Purpose Of The Study
- To investigate the association between statin and/or metformin use and overall survival in men with PC.
- To clarify the impact of these medications based on PC treatment and patient characteristics.
Main Methods
- Retrospective analysis of French national health databases (2006-2018) including over 521,052 PC patients.
- Evaluation of overall survival based on statin and/or metformin exposure, stratified by PC treatment (androgen deprivation therapy, radical prostatectomy).
- Causal analysis using a Bayesian network and AI-driven semantic elicitation for validation.
Main Results
- Highest mortality observed in PC patients using both statins and metformin (HR 2.29).
- Statin monotherapy (HR 0.91) and combined statin-metformin use (HR 0.86) showed a protective effect in patients receiving androgen deprivation therapy.
- Metformin monotherapy (HR 1.07) was associated with higher mortality in this subgroup.
- No protective effect of statins was found in PC patients treated with radical prostatectomy.
Conclusions
- Statin use may confer a survival benefit for prostate cancer patients undergoing androgen deprivation therapy.
- The combination of statins and metformin might offer a protective effect in specific prostate cancer treatment contexts.
- Metformin alone may be associated with increased mortality in prostate cancer patients, warranting further investigation.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...